A molecular convergence in the triad of parkinson’s disease, depressive disorder and gut health is revealed by the inflammation-miRNA axis

This study identifies a specific inflammation-miRNA pathway as a common molecular mechanism connecting the pathophysiology of PD, DD, and gut dysfunction. This pattern represents a critical point of convergence that drives a shared, bidirectional inflammatory cascade along the gut-brain axis. Targeting this miRNA triad could provide a new therapeutic approach for addressing the motor, psychiatric, and GI symptoms of these interconnected disorders simultaneously.

Authors

Institutions

Publication Details

Journal
Journal of Neuroinflammation
Published
2025-11-04
DOI
https://doi.org/10.1186/s12974-025-03608-y
Citations
1
Primary Topic
Tryptophan and brain disorders
Type
article
Field-Weighted Citation Impact
0.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A molecular convergence in the triad of parkinson’s disease, depressive disorder and gut health is revealed by the inflammation-miRNA axis

J. Javier Meana, Lluís Miquel-Rio, Analı́a Bortolozzi, Luís F. Callado et al.
1 citations
Journal of Neuroinflammation
Tryptophan and brain disorders
0.58
article

A molecular convergence in the triad of parkinson’s disease, depressive disorder and gut health is revealed by the inflammation-miRNA axis

J. Javier Meana, Lluís Miquel-Rio, Analı́a Bortolozzi, Luís F. Callado, Verónica Paz, Unai Sarriés-Serrano, Judith Jericó-Escolar, Claudia Yanes-Castilla
article en
1 citations

Abstract

This study identifies a specific inflammation-miRNA pathway as a common molecular mechanism connecting the pathophysiology of PD, DD, and gut dysfunction. This pattern represents a critical point of convergence that drives a shared, bidirectional inflammatory cascade along the gut-brain axis. Targeting this miRNA triad could provide a new therapeutic approach for addressing the motor, psychiatric, and GI symptoms of these interconnected disorders simultaneously.

Journal of NeuroinflammationVol. 22(1)
Universitat Autònoma de Barcelona (ES), University of the Basque Country (ES), Instituto de Salud Carlos III (ES), BioCruces Health research Institute (ES), Institut d'Investigacions Biomèdiques de Barcelona (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Medical Research Network (US), Universitat de Barcelona (ES)
Fundació la Marató de TV3, Ministerio de Ciencia, Innovación y Universidades, Generalitat de Catalunya, Eusko Jaurlaritza, Universitat de Barcelona, Centro de Investigación Biomédica en Red de Salud Mental, Universitat Autònoma de Barcelona, Agència de Gestió d'Ajuts Universitaris i de Recerca, Agencia Estatal de Investigación
Openalex Percentile: Top 30%
Tryptophan and brain disorders
0.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.